Olumiant 4 mg, comprimés pelliculés

7680662150027 CH-66215 Tabletten
Olumiant 4 mg, comprimés pelliculés
Olumiant 4 mg, comprimés pelliculés
Olumiant 4 mg, comprimés pelliculés
1 / 3
google

Article details

Package size
28
Selling units
28
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
10/10/2025
Patient information leaflet
Français
10/10/2025
Patient information leaflet
Italien
10/10/2025
Summary of Product Characteristics
Allemand
13/09/2025
Summary of Product Characteristics
Français
13/09/2025
Summary of Product Characteristics
Italien
13/09/2025

Detailed composition

Substance Quantity Type Category
FTAB
4.0 MG Substance Wirkstoff (Principe actif)
FTAB
50.0 MG Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance FNIDK
FTAB
- Substance FTODK
FTAB
0.7608 MG Substance HBESI

Reimbursement information

Public price
CHF 963.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2017

Authorization holder

Eli Lilly (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
66215
Drug name
Olumiant, comprimés pelliculés
Galenic form
FILM
ATC Code
L04AA37
Authorization status
Z
Dispensing category
B
First authorization
19/06/2017
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine

Package details

Description (FR)
OLUMIANT cpr pell 4 mg 28 pce
Description (DE)
OLUMIANT Filmtabl 4 mg 28 Stk
Market launch
19/06/2017
Narcotic (BTM)
No

Other package sizes (1)

OLUMIANT cpr pell 2 mg 28 pce
28 TABL
GTIN: 7680662150010
View